Same-day dispatch on orders by 2 PM ETFree shipping over $150Save up to 50% with volume pricing
0
  1. Home
  2. Shop
  3. Endocrine
  4. TESA / IPA Blend

Endocrine · Two-peptide blend: Tesamorelin 10 mg + Ipamorelin 5 mg

TESA / IPA Blend

15 mg · 2-compound blend

$120.00per vial

Size$8.00/mg

15 mg Lyophilised · sealed vial

Quantity10+ of one compound: 40% off

Choose a quantity
1

Same-day dispatch on orders by 2 PM ET, Monday to Friday

Arrives in 2 business days, tracked

Free shipping over $150

Earn Research Credit on top of your discount. VIP earns 3x more.
  • 7 tests, every lotIndependent lab
  • 2 Day ShippingFrom the USA, tracked
  • Encrypted checkoutSSL secured
  • PassedSterility & endotoxin
  • PassedIdentity & purity, 99.46%

For in-vitro research use only. Not for human or animal use.

Researchers also add

01Verified test results

Every lot, independently tested.

TESA / IPA Blend lot SA-TIP-2610 was tested Oct 8, 2026 at an independent laboratory before it shipped. Every value is printed against its limit, so a pass means something.

Independent labIndependent third-party laboratorySample data

Certificate of analysis

99.46%

Purity by HPLC

Profile drawn from the reported purity

Lot
SA-TIP-2610
Tested
Oct 8, 2026
Labelled
15 mg
Measured
15.24 mg
7 of 7 within limitsQR on every label
Full release panel7 passed · 0 flagged
  • PurityHPLC · limit ≥ 99.0%99.46%Pass
  • IdentityMass spectrometry · limit Each componentAll confirmedPass
  • Net contentQuantitative HPLC · limit ≥ 15 mg15.24 mgPass
  • EndotoxinLAL assay · limit ≤ 0.5 EU/mg0.09 EU/mgPass
  • SterilityMembrane filtration · limit No growthNo growthPass
  • Heavy metalsICP-MS · limit ≤ 10 ppm total0.8 ppmPass
  • MoistureKarl Fischer · limit ≤ 8.0%4.0%Pass

Purity by HPLC, identity by mass spectrometry, net content by quantitative HPLC, endotoxin by LAL, sterility by membrane filtration, heavy metals by ICP-MS and moisture by Karl Fischer. Report SA-TIP-2610-01, Oct 8, 2026. Open the lot record.

Every lot on record

Open any lot's certificate. Your order ships from the current released lot, and its QR code opens this record.

All 2 TESA / IPA Blend lots
Latest
TESA / IPA Blend 15 mgLot SA-TIP-2610

99.46%

HPLC purity

Labelled15 mgMeasured15.24 mg+1.6%
  • IdentityConfirmed
  • EndotoxinPass
  • SterilityNo growth
  • Heavy metalsPass

Tested Oct 8, 2026 · 7/7 assays · sample

TESA / IPA Blend 15 mgLot SA-TIP-2609

99.47%

HPLC purity

Labelled15 mgMeasured15.40 mg+2.7%
  • IdentityConfirmed
  • EndotoxinPass
  • SterilityNo growth
  • Heavy metalsPass

Tested Sep 10, 2026 · 7/7 assays · sample

02Verify your vial

Three steps from label to lab.

  1. 01Scan the label

    Every vial label carries a QR code. Point your phone camera at it.

  2. 02Land on its record

    The code opens that lot's certificate with every assay value. No phone? Type the lot from your packing slip on Verify a lot.

  3. 03Check it with the lab

    Each signed certificate links to the lab's own verification page, so the report can be confirmed independently of us.

03Analytical identity

TESA / IPA Blend, molecule by molecule.

Studied in paired GHRH-receptor and ghrelin-receptor models in vitro.

CompoundTwo-peptide blend: Tesamorelin 10 mg + Ipamorelin 5 mg
FormulaPer component
Molecular weightPer component
Type2 compounds
FormLyophilised powder, 15 mg
StorageSealed at -20 °C, away from light and moisture

Components

  • Tesamorelin10 mg
  • Ipamorelin5 mg

Each component is confirmed separately on the lot certificate.

2 structuresStacked in blend order
Residues · hover to locate49 residues

Tesamorelin10 mg · 44 residues

Ipamorelin5 mg · 5 residues

Tesamorelin
C221 N72 O67 S1
Ipamorelin
C38 N9 O5
Heavy atoms
413
Components
2 of 2 modelled

Each component is built from its own sequence with ideal bond lengths and angles, so every connection is exact. They are separate molecules in the vial, not bonded to each other; the stack is for viewing only. Poses are idealised, not measured conformations. Each component is confirmed separately on the lot certificate.

Structure viewer

04In the lab

How TESA / IPA Blend is studied to work.

In laboratory research tesamorelin, a GHRH(1-44) analog, resisted DPP-IV breakdown and raised GH and IGF-1, while ipamorelin released GH through the GHRP (ghrelin) receptor without an ACTH or cortisol rise. The two have been studied separately; no paper has tested them together.

Blend

TESA / IPA BlendBlend of tesamorelin and ipamorelin
  1. Tesamorelin

    GH axis activation

    • GH
    • IGF-1

    Endpoint studied

    Raised GH and IGF-1

    Resisted DPP-IV, degraded more slowly in plasma than hGRF(1-44), and repeat runs raised GH and IGF-1.

    Ferdinandi 2007 · PMID 17214611
  2. Ipamorelin

    Selective GH release

    • GHRP receptor
    • GH

    Endpoint studied

    GH release

    Released GH from pituitary cells as potently as GHRP-6; ACTH and cortisol did not rise in laboratory models.

    Raun 1998 · PMID 9849822

Pathways as reported in the cited laboratory studies, for each compound in the blend. For in-vitro research use only.

05Research history

11 years in the literature.

5 milestones, each linked to its PubMed record

  1. 1998

    Ipamorelin · European Journal of Endocrinology

    Ipamorelin is described

    A pentapeptide from a GHRP-1 chemistry program releases GH like GHRP-6 but leaves ACTH and cortisol unchanged.

    PubMed · PMID 9849822
  2. 1999

    Ipamorelin · Growth Hormone & IGF Research

    Longitudinal bone growth

    Raised the longitudinal bone growth rate in a growth model, with total IGF-I unchanged.

    PubMed · PMID 10373343
  3. 2000

    Ipamorelin · The Journal of Endocrinology

    Bone mineral content

    Raised bone mineral content in a long-term model through larger bone dimensions, not denser bone.

    PubMed · PMID 10828840
  4. 2007

    Tesamorelin · Basic & Clinical Pharmacology & Toxicology

    Lab pharmacology of TH9507

    The hexenoyl group resists DPP-IV and slows plasma breakdown; repeat runs raise GH and IGF-1 in laboratory models.

    PubMed · PMID 17214611
  5. 2009

    Tesamorelin · Expert Opinion on Investigational Drugs

    A development review

    A review traces how tesamorelin was developed as a synthetic analog of human growth hormone releasing factor.

    PubMed · PMID 19243281 Latest

Laboratory research only, cited for research context. Not a claim about use in people.

06Questions

Frequently asked questions.

About TESA / IPA Blend, its certificate and your order.

Need assistance? We’re here to help.

Email [email protected], Monday to Friday. A person replies within one business day.

01Which lot will I receive?

The current released lot, SA-TIP-2610. Scan the QR code on the vial label to open its certificate. The lot number is also on your packing slip, and the full certificate is here.

02Is the certificate real, and can I check it?

Every certificate is issued by an independent laboratory. Each lot has its own public record page with every assay value, and a link to verify the report on the lab's own site once the signed PDF is posted.

03Why does net content show more than 15 mg?

Vials are filled slightly over the labelled mass so that every vial meets it. Net content is measured on each lot and published as a number, not a pass.

04What if the vial arrives without vacuum or damaged?

Email [email protected] within 7 days with your order number and a photo and we will replace it.

05When will it ship?

Orders by 2 PM ET on a weekday ship the same day, with tracking emailed when the label prints.

06Is TESA / IPA Blend for human use?

No. It is sold strictly for in-vitro laboratory research and is not for human or animal use of any kind.

07Complete the box

Every vial counts toward your price.

3+ vials 25% off and 5+ vials 30% off across any mix, 10+ of one compound 40% off, 50+ of one compound 50% off.

Build a box
TESA / IPA Blend15 mg · $120.00
1

View

Certificate

Loading certificate